2023 annual financial data
RenovoRx, Inc. 2023 Operating margin
RenovoRx, Inc. 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -11,396,000 USD and net income was -10,232,000 USD.
Operating cash flow was -10,258,000 USD.
Get free RenovoRx, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -11,396,000 USD
- Net income
- -10,232,000 USD
- Operating cash flow
- -10,258,000 USD